A Multinational Trial To Evaluate The Parachute Implant System (PARACHUTE)
A MULTINATIONAL TRIAL TO EVALUATE THE PARACHUTE IMPLANT SYSTEM: PARACHUTE PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE
Sponsor: CardioKinetix, Inc
Terminated
Company closed
Other terminated trials from CardioKinetix, Inc
- Heart Failure · Jun 2017
- Congestive Heart Failure · Phase PHASE3 · Jun 2017
- Ischemic Heart Failure · Phase NA · Jun 2017
- Heart Failure · Jun 2017
- Heart Failure · Jun 2017
More terminations from CardioKinetix, Inc
A PHASE3 clinical study on Heart Failure and Myocardial Infarction, this trial is terminated or withdrawn. The trial is conducted by CardioKinetix, Inc and has accumulated 6 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jul 2017 — Jun 2018 [monthly]
Terminated PHASE3
Status: Active Not Recruiting → Terminated
▶ Show 1 earlier version
-
Jan 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CardioKinetix, Inc
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amsterdam, Netherlands , Belgrade, Serbia , Bron, France , Cambridge, United Kingdom , Heidelberg, Germany , Lisbon, Portugal , Ljubljana, Slovenia , London, United Kingdom , Massy, France , Riga, Latvia and 2 more locations